- ROTH Capital Partners’ annual spring investment conference will provide insights into a variety of small-to-mid cap opportunities, including several in varied health and environmental sustainability sectors
- The 33rd Annual ROTH Conference will take place March 15-17 in an online format designed to facilitate connections between companies and investors while maintaining infectious disease safety protocols during the ongoing pandemic
- Varied ROTH partners with buy ratings as well as some non-covered companies will field representatives for one-on-one or small-group interviews, fireside chats and investor presentations
- The conference’s three-day agenda also includes a panels on COVID therapeutics, cancer technologies and a new vision for the electrical power grid infrastructure
ROTH Capital Partners’ spring conference, now in its 33rd year, is ready to connect new investments that key in on global megatrends for the foreseeable future. Two particularly hot areas of interest center around sustainable energy and emerging healthcare industry sectors.
Nineteen companies will feature heavily among presenters, one-on-one interviews and fireside chats focusing on global efforts to use best practices in managing humanity’s impact on the world around us at the conference. The event is scheduled to take place March 15-17 in a virtual format that is responsive to the health threat posed by the COVID-19 crisis and at the same time fulfilling for participating small cap businesses and money interests.
The 19 ROTH sustainability partners represent markets in residential solar, inverters and energy storage, tech modules and solar positioning “trackers,” developers and other non-solar sectors such as wind energy.
The three-day conference agenda will include a panel featuring C-level executives discussing efforts to reimagine the electrical grid’s power infrastructure and develop dormant potential. ROTH sees sustainability as a trend that has the potential to create substantial value for the companies harnessing the opportunity and also the potential to destroy value for those who ignore or neglect anticipated change that looms ahead.
The panel will explore the need for evolution in the electrical grid, how existing market interests are expected to respond to sector evolution and what elements will shape a winning formula as things unfold.
All but three of the 19 partners were listed as buy recommendations by ROTH at the beginning of the month; ROTH maintained a neutral position on those in the minority.
Healthcare industry sectors accessible through the agenda’s interviews and presentations include biotechnology, cancer and pharmaceuticals.
Panels addressing topics in the oncology, ophthalmology, women’s health and COVID-19 therapy spaces will include 24 companies, 18 of which are covered partners with buy ratings. Three additional companies will provide information about themselves in fireside chats.
In the biotechnology space, ROTH has coverage on 18 confirmed partners with buy ratings in sectors including oncology, anti-infectives, anti-inflammatories, gastrointestinal, ophthalmology, central nervous system, tech platforms and varied disease indications. Fourteen of those companies will participate in panels related to oncology and COVID-19 therapeutics advances.
All of the companies will be accessible through one-on-one visits and / or investor presentations, along with eight covered companies in the pharmaceuticals space and 13 in the cancer space.
The breadth of opportunity represented in the conference’s events demonstrates ROTH’s established ability to link small-to-mid cap companies with interested investors. Last year’s event drew over 1,000 participants and representatives from 350 companies worldwide despite the limitations posed by the pandemic mere days before the conference’s launch.
For more information on how to register for this year’s event, visit the company’s website at https://ibn.fm/PcAoj.
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
InvestorWire is part of the InvestorBrandNetwork.